NDC 43386-050

GaviLyte - N

Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate

GaviLyte - N is a Oral Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals,inc.. The primary component is Polyethylene Glycol 3350; Sodium Chloride; Sodium Bicarbonate; Potassium Chloride.

Product ID43386-050_3ff4d772-6527-4791-9236-e1a97878a200
NDC43386-050
Product TypeHuman Prescription Drug
Proprietary NameGaviLyte - N
Generic NamePolyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate
Dosage FormPowder, For Solution
Route of AdministrationORAL
Marketing Start Date2009-05-28
Marketing CategoryANDA / ANDA
Application NumberANDA090019
Labeler NameLupin Pharmaceuticals,Inc.
Substance NamePOLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; SODIUM BICARBONATE; POTASSIUM CHLORIDE
Active Ingredient Strength420 g/438.4g; g/438.4g; g/438.4g; g/438.4g
Pharm ClassesOsmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 43386-050-19

438.4 g in 1 BOTTLE (43386-050-19)
Marketing Start Date2009-05-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43386-050-19 [43386005019]

GaviLyte - N POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA090019
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-05-28

Drug Details

Active Ingredients

IngredientStrength
POLYETHYLENE GLYCOL 3350420 g/438.4g

OpenFDA Data

SPL SET ID:27195187-75a3-431f-90d9-84da1b94e849
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 979099
  • 801054
  • UPC Code
  • 0343386050192
  • 0343386200023
  • Pharmacological Class

    • Osmotic Activity [MoA]
    • Osmotic Laxative [EPC]
    • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]
    • Potassium Compounds [CS]
    • Potassium Salt [EPC]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]
    • Osmotic Activity [MoA]
    • Osmotic Laxative [EPC]
    • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]
    • Potassium Compounds [CS]
    • Potassium Salt [EPC]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]

    Medicade Reported Pricing

    43386050011 FAMOTIDINE 40 MG/5 ML SUSP

    Pricing Unit: ML | Drug Type:

    43386005019 GAVILYTE-N SOLUTION

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "GaviLyte - N" or generic name "Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride And Sodium Bicarbonate"

    NDCBrand NameGeneric Name
    43386-050GaviLyte - Npolyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate
    40032-050Polyethylene Glycol-3350, Sodium Chloride, Potassium Chloride and Sodium BicarbonatePolyethylene Glycol-3350, Sodium Chloride, Potassium Chloride and Sodium Bicarbonate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.